What is the difference between Chonluten and Thymulin?

Chonluten: Tripeptide bioregulator targeting bronchial epithelial cells; normalizes gene expression in bronchial tissue; promotes epithelial regeneration Thymulin: Zinc-dependent peptide that promotes T-lymphocyte differentiation, enhances natural killer cell activity, and regulates cytokine balance. Requires zinc cofactor for biological activity.

Is Chonluten FDA approved?

Chonluten is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

Is Thymulin FDA approved?

Thymulin is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Chonluten administered in research settings?

In research settings, Chonluten is typically administered via the oral or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

How is Thymulin administered in research settings?

In research settings, Thymulin is typically administered via the subcutaneous route. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Chonluten vs Thymulin

Peptide Comparison

Chonluten vs Thymulin

Name: Chonluten vs Thymulin — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Immune & Thymic peptides.

Chonluten

Bronchogen

RecoveryNot EvaluatedResearch Only

Half-life: Unknown

2 providers listed

Full Chonluten profile →

Thymulin

FTS

RecoveryNot EvaluatedResearch Only

26 providers listed

Full Thymulin profile →

Bottom line

Thymulin is carried by more providers on PeptideBase (26 vs 2); otherwise the two are closely matched on the measures we track.

Quick Verdict

Chonluten

Evidence

Review-level

Thymulin

Evidence

Preclinical

Which One Should You Choose?

Your goal	Better option
Oral administration option	Chonluten
More provider options (2 vs 26)	Thymulin

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Chonluten

Thymulin

Mechanism Family

Immune & Thymic

Half-life

Unknown

—

FDA Status

not evaluated

Admin Routes

oral, subcutaneous

subcutaneous

Availability

Research Only

Providers

2 listed

26 listed

Avail. Notes

Russian peptide bioregulator (Glu-Asp-Lys) from Khavinson Institute. Developed for lung health. No FDA approval, no NDA or IND. Not on any FDA list. Research chemical in US.

—

Research Evidence

Chonluten

Review-levelReview · 2 key studies · most recent 2022

Thymulin

PreclinicalReview · 2 key studies · dated evidence base — most recent 2009

Research Citations

Chonluten

Review2022 · International Journal of Molecular Sciences

Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers

Review2021 · Molecules

Peptide Regulation of Gene Expression: A Systematic Review

Thymulin

Review2009 · Annals of the New York Academy of Sciences

The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptid…

Animal2007 · International Immunopharmacology

In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic coli…

About Chonluten

Tripeptide bioregulator targeting bronchial epithelial cells; normalizes gene expression in bronchial tissue; promotes epithelial regeneration

Research Areas

bronchial repairlung tissue regenerationrespiratory anti-inflammatory

About Thymulin

Zinc-dependent peptide that promotes T-lymphocyte differentiation, enhances natural killer cell activity, and regulates cytokine balance. Requires zinc cofactor for biological activity.

Research Areas

immune modulationT-cell maturationNK cell supportanti-inflammatory

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Chonluten

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Thymulin

Absolute Contraindications

Under clinical review

Being verified by our medical team before we display contraindications for this peptide.

Price (per mg)

Chonluten

$2.70/mg

$2.00 – $3.10 range

8 vendors

View price index →Find providers →

Thymulin

Not enough vendor pricing yet.

Find Providers

Where to source these peptides

Providers offering

Chonluten

2 listed

Browse directory →

Providers offering

Thymulin

26 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Immune & Thymic Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated July 22, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Chonluten vs Thymulin — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/chonluten/thymulin

https://peptidebase.io/peptides/compare/chonluten/thymulin Methodology License Download JSON Download CSV